Skip to main content
Navigate Up
Sign In

This CU Drug Trial May Be A Cure For An Aggressive Strain Of Leukemia

Colorado Public Radio

Any cancer diagnosis is terrifying.

But for adults, the rare Acute Myeloid Leukemia, or AML, is especially frightening.

Karl Leason, a retired music teacher in Cañon City, was "never so panicked in my entire life" when he received his AML diagnosis. He was given six months, maybe a year, to live.

"Your life is over with and you know what ... I loved my life, I loved it from the time I could remember. And I always used to say when I was a little kid I wanted to live to be 106 and they used to laugh at me about that," Leason said. "And here I was looking at over in six months."

The normal course of treatment for AML is intense chemotherapy. But Leason's doctor offered another pat, a clinical trial of a new treatment at the University of Colorado’s Anschutz Medical Campus. Leason drove to Aurora and met the physician leading the study, Dr. Daniel Pollyea.

Karl Leason was enjoying his retirement when an Acute 
Myeloid Leukemia diagnosis rocked his world.
Courtesy of Karl Leason

“And he gave me the one thing I hadn’t had for weeks. And that was hope," Leason said.

Click here to